The Plum A+ Infusion Systems are a multipurpose family of devices that provides precise delivery ...

FDA Device Recall #Z-2677-2017 — Class II — February 1, 2013

Recall Summary

Recall Number Z-2677-2017
Classification Class II — Moderate risk
Date Initiated February 1, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm ICU
Location Lake Forest, IL
Product Type Devices
Quantity 71 units

Product Description

The Plum A+ Infusion Systems are a multipurpose family of devices that provides precise delivery of multiple therapies across the general spectrum of clinical care. The Plum A+ family infusion pumps are self contained, microprocessor based infusion devices. The pumps are available in single channel and in triple channel pumping mechanism types.

Reason for Recall

A possible interruption of therapy when an E321 error code occurs while using the infuser, which is caused by battery issues.

Distribution Pattern

Nationwide, Worldwide

Lot / Code Information

List number: 11973 Serial Numbers 12570148 12570150 12570154 12570163 12570170 12570177 12570204 12570211 12570212 12570255 12570270 12570319 12570359 12570385 12570413 12570425 12570455 12570487 12570662 12570695 12570854 12570915 12571080 12571243 12571437 12571631 12571692 12571776 12571826 12571835 12571837 12571842 12571877 12571880 12571886 12572317 12572369 12572586 12572909 12573547 12573567 12573837 12573990 12574424 12574501 12574524 12574556 12574599 12574619 12574731 12574749 12574853 12574858 12574860 12574865 12574961 12575626 12575698 12575886 12576125 12576443 12576485 12576518 12576593 12576609 12576710 12576722 12577271 12577685 12578856 12579183

Other Recalls from ICU

Recall # Classification Product Date
Z-2680-2017 Class II The Plum A+ Infusion Systems are a multipurpose... Feb 1, 2013
Z-2682-2017 Class II The Plum A+ Infusion Systems are a multipurpose... Feb 1, 2013
Z-2683-2017 Class II The Plum A+ Infusion Systems are a multipurpose... Feb 1, 2013
Z-2681-2017 Class II The Plum A+ Infusion Systems are a multipurpose... Feb 1, 2013
Z-2676-2017 Class II The Plum A+ Infusion Systems are a multipurpose... Feb 1, 2013

Frequently Asked Questions

Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.